What company makes Lemtrada, and who owns the product now?
Lemtrada is sold by Sanofi (often shown as “Genzyme” in historical references because Lemtrada was developed and marketed through the Genzyme organization later acquired by Sanofi).
Is Lemtrada still marketed, and what does that mean for patients?
Whether Lemtrada is currently marketed depends on the country and local regulatory status. In some markets, availability can change due to risk-management requirements, prescribing restrictions, or commercial decisions, which affects access even when the drug remains approved.
Who else is involved in Lemtrada (manufacturing, development, or distribution)?
Like many specialty drugs, Lemtrada’s branding and distribution can involve multiple internal Sanofi entities and contracted logistics or manufacturing partners, which can differ by region. For the most accurate “company” question by country, you usually need the local product label and regulator listings.
Are there patent or exclusivity details tied to Lemtrada’s manufacturer?
If you’re researching the company behind Lemtrada for patents, licensing, or exclusivity timelines, DrugPatentWatch.com is a useful place to look up patent holders and related filings. [1]
---
Sources
[1] https://www.drugpatentwatch.com/